Table 2 Statistics on expression imbalances across human chromosomes.
From: A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer
Chromosome | Genes Considered | Genes In Regions With Expression Imbalance | Genes In Regions With Expression Gain | Genes In Regions With Expression Loss |
|---|---|---|---|---|
chr1 | 2976 | 418 (14.0%) | 109 (3.7%) | 309 (10.4%) |
chr2 | 2236 | 550 (24.6%) | 296 (13.2%) | 254 (11.4%) |
chr3 | 1815 | 444 (24.5%) | 203 (11.2%) | 241 (13.3%) |
chr4 | 1273 | 347 (27.3%) | 0 (0.0%) | 347 (27.3%) |
chr5 | 1496 | 489 (32.7%) | 219 (14.6%) | 270 (18.0%) |
chr6 | 1767 | 355 (20.1%) | 240 (13.6%) | 115 (6.5%) |
chr7 | 1537 | 585 (38.1%) | 451 (29.3%) | 134 (8.7%) |
chr8 | 1152 | 311 (27.0%) | 311 (27.0%) | 0 (0.0%) |
chr9 | 1215 | 193 (15.9%) | 0 (0.0%) | 193 (15.9%) |
chr10 | 1255 | 271 (21.6%) | 0 (0.0%) | 271 (21.6%) |
chr11 | 1781 | 515 (28.9%) | 328 (18.4%) | 187 (10.5%) |
chr12 | 1584 | 546 (34.5%) | 279 (17.6%) | 267 (16.9%) |
chr13 | 683 | 180 (26.4%) | 180 (26.4%) | 0 (0.0%) |
chr14 | 1061 | 206 (19.4%) | 27 (2.5%) | 179 (16.9%) |
chr15 | 951 | 306 (32.2%) | 0 (0.0%) | 306 (32.2%) |
chr16 | 1279 | 349 (27.3%) | 103 (8.1%) | 246 (19.2%) |
chr17 | 1807 | 329 (18.2%) | 120 (6.6%) | 209 (11.6%) |
chr18 | 546 | 246 (45.1%) | 0 (0.0%) | 246 (45.1%) |
chr19 | 1636 | 339 (20.7%) | 194 (11.9%) | 145 (8.9%) |
chr20 | 917 | 386 (42.1%) | 386 (42.1%) | 0 (0.0%) |
chr21 | 358 | 118 (33.0%) | 68 (19.0%) | 50 (14.0%) |
chr22 | 736 | 192 (26.1%) | 0 (0.0%) | 192 (26.1%) |
chrX | 1042 | 217 (20.8%) | 217 (20.8%) | 0 (0.0%) |
chrY | 96 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
TOTAL | 31199 | 7892 (25.3%) | 3731 (12.0%) | 4161 (13.3%) |